Skip to main content
. 2023 Apr 16;83(12):1953–1967. doi: 10.1158/0008-5472.CAN-22-3848

Figure 2.

Figure 2. Mutation of Keap1 or Nrf2 is not sufficient to initiate lung tumorigenesis. A, Overall survival of Keap1/Nrf2 mutant mice. Keap1/Nrf2+/+ (n = 17), Keap1R554Q/+ (n = 8); Keap1R554Q/R554Q (n = 11); Nrf2D29H/+ (n = 15). ns, not significant [log-rank (Mantel–Cox) test]. B, Lung tumor-free survival of Keap1/Nrf2 mutant mice. Keap1/Nrf2+/+ (n = 11); Keap1R554Q/+ (n = 4); Keap1R554Q/R554Q (n = 8); Nrf2D29H/+ (n = 11). C, Representative hematoxylin and eosin staining of mouse lung depicting normal bronchiolar and alveolar cells. Scale bars, 100 μm (top) and 20 μm (bottom).

Mutation of Keap1 or Nrf2 is not sufficient to initiate lung tumorigenesis. A, Overall survival of Keap1/Nrf2 mutant mice. Keap1/Nrf2+/+ (n = 17), Keap1R554Q/+ (n = 8); Keap1R554Q/R554Q (n = 11); Nrf2D29H/+ (n = 15). ns, not significant [log-rank (Mantel–Cox) test]. B, Lung tumor-free survival of Keap1/Nrf2 mutant mice. Keap1/Nrf2+/+ (n = 11); Keap1R554Q/+ (n = 4); Keap1R554Q/R554Q (n = 8); Nrf2D29H/+ (n = 11). C, Representative hematoxylin and eosin staining of mouse lung depicting normal bronchiolar and alveolar cells. Scale bars, 100 μm (top) and 20 μm (bottom).